March 2025
Novo Nordisk looks into starting GLP-1 drug trials for addiction
Glucagon-Like Peptide 1, Addictive Behavior
ITM Reports Positive Phase 3 Data for Radiopharmaceutical ITM-11 in Neuroendocrine Tumors, Challenging Novartis’ Lutathera
ITM-11, radiopharmaceutical, Phase 3 COMPETE trial, neuroendocrine tumors, Lutathera, Novartis
Senators grill Trump’s NIH nominee on vaccines and funding
United States National Institutes of Health, Vaccines, Bhattacharya, Senators, Trump ‘s, Senators, research
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
targeted protein degradation, neurodegenerative diseases, TRIM21, TRIMTAC degraders, CNS therapeutics, seed funding, biotech startup
Freed Raises $30M to Transform Medical Documentation with AI-Powered Assistant
AI medical scribe, clinician burnout, administrative burden, healthcare technology, Series A funding
Persica Reports Positive Phase 1b Results for Novel Antibiotic Treatment in Chronic Low Back Pain
Persica Pharmaceuticals, PP353, chronic low back pain, antibiotic therapy, Modic changes, Phase 1b clinical trial
In an unusual move, Lilly seeks pitches from US states for slice of $27B buildout
Eli Lilly, Investments, United States, Lilly ‘s
FDA puts BioNTechs malaria vaccine on clinical hold
United States Food and Drug Administration, Malaria, Study on Hold, Vaccines, BioNTech ‘s, Clinical Trials
Bayer Expects Pharma Sales Dip in 2025 Despite Upcoming Launches
Bayer, pharmaceutical sales, revenue decline, new drug launches, Xarelto patent expiration